ArticlePloS one2020

Comparison of one-year results of photodynamic therapy combined with ranibizumab or aflibercept for treating polypoidal choroidal vasculopathy.

Arisa Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.